GeneScience Pharmaceuticals Co., Ltd.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
projects to enhance and expand business potential and scope - Explore the dormant and discontinued<br />
projects of <strong>GeneScience</strong> <strong>Pharmaceuticals</strong> <strong>Co</strong>., <strong>Ltd</strong>. and identify potential opportunities in those areas -<br />
Avoid Intellectual Property Rights related issues<br />
Browse <strong>Co</strong>mplete Report with TOC @ http://www.idatainsights.com/reports-landingpage.php?id=124226/neurovive-pharmaceutical-ab-product-pipeline-review-2015<br />
To Get Sample <strong>Co</strong>py of Report visit @ http://www.idatainsights.com/reports-landingpage.php?id=124226/neurovive-pharmaceutical-ab-product-pipeline-review-2015<br />
Table of <strong>Co</strong>ntents<br />
Table of <strong>Co</strong>ntents 2<br />
List of Tables 4<br />
List of Figures 4<br />
<strong>GeneScience</strong> Pharmaceutical AB Snapshot 5<br />
<strong>GeneScience</strong> Pharmaceutical AB Overview 5<br />
Key Information 5<br />
Key Facts 5<br />
<strong>GeneScience</strong> Pharmaceutical AB - Research and Development Overview 6<br />
Key Therapeutic Areas 6<br />
NeuroVive Pharmaceutical AB - Pipeline Review 8<br />
Pipeline Products by Stage of Development 8<br />
Pipeline Products - Monotherapy 9<br />
Pipeline Products - Out-Licensed Products 10<br />
Out-Licensed Products/<strong>Co</strong>mbination Treatment Modalities 11<br />
<strong>GeneScience</strong> Pharmaceutical AB - Pipeline Products Glance 12<br />
<strong>GeneScience</strong> Pharmaceutical AB - Late Stage Pipeline Products 12<br />
Phase III Products/<strong>Co</strong>mbination Treatment Modalities 12<br />
<strong>GeneScience</strong> Pharmaceutical AB - Clinical Stage Pipeline Products 13<br />
Phase II Products/<strong>Co</strong>mbination Treatment Modalities 13<br />
<strong>GeneScience</strong> Pharmaceutical AB - Early Stage Pipeline Products 14<br />
Preclinical Products/<strong>Co</strong>mbination Treatment Modalities 14<br />
2
Change language